Year |
Citation |
Score |
Low-probability matches (unlikely to be authored by this person) |
2015 |
Curtis BM, Barrett BJ, Parfrey PS. Randomized controlled trials 1: Design. Methods in Molecular Biology (Clifton, N.J.). 1281: 159-75. PMID 25694309 DOI: 10.1007/978-1-4939-2428-8_9 |
0.01 |
|
2014 |
Williams CE, Curtis BM, Randell EW, Foley RN, Parfrey PS. Cardiac biomarkers and health-related quality of life in new hemodialysis patients without symptomatic cardiac disease. Canadian Journal of Kidney Health and Disease. 1: 16. PMID 26038709 DOI: 10.1186/2054-3581-1-16 |
0.01 |
|
2014 |
Curtis BM, Leix KA, Ji Y, Glaves RSE, Ash DE, Mohanty DK. Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death Biochemical and Biophysical Research Communications. 450: 208-212. PMID 24878532 DOI: 10.1016/j.bbrc.2014.05.087 |
0.01 |
|
2013 |
Curtis B, Payne TJ, Ash DE, Mohanty DK. Secondary amines containing one aromatic nitro group: Preparation, nitrosation, sustained nitric oxide release, and the synergistic effects of released nitric oxide and an arginase inhibitor on vascular smooth muscle cell proliferation Bioorganic and Medicinal Chemistry. 21: 1123-1135. PMID 23375096 DOI: 10.1016/j.bmc.2012.12.043 |
0.01 |
|
2013 |
Mohanty D, Curtis B, Payne T, Ash D. P58 Nitric Oxide. 31: S37-S38. DOI: 10.1016/J.NIOX.2013.02.060 |
0.01 |
|
2010 |
Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease Clinical Journal of the American Society of Nephrology. 5: 805-813. PMID 20378644 DOI: 10.2215/CJN.07761109 |
0.01 |
|
2009 |
Foley RN, Curtis BM, Parfrey PS. Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: A randomized trial Clinical Journal of the American Society of Nephrology. 4: 726-733. PMID 19339412 DOI: 10.2215/Cjn.04950908 |
0.01 |
|
2009 |
Curtis BM, Barrett BJ, Parfrey PS. The design of randomized controlled trials. Methods in Molecular Biology (Clifton, N.J.). 473: 95-111. PMID 19160733 DOI: 10.1007/978-1-59745-385-1_5 |
0.01 |
|
2008 |
Foley RN, Curtis BM, Parfrey PS. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy Clinical Journal of the American Society of Nephrology. 3: 1669-1675. PMID 18922988 DOI: 10.2215/Cjn.02100508 |
0.01 |
|
2007 |
Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 50: 733-42. PMID 17954286 DOI: 10.1053/j.ajkd.2007.08.004 |
0.01 |
|
2005 |
Curtis BM, Parfrey PS. Congestive heart failure in chronic kidney disease: Disease-specific mechanisms of systolic and diastolic heart failure and management Cardiology Clinics. 23: 275-284. PMID 16084277 DOI: 10.1016/J.Ccl.2005.04.002 |
0.01 |
|
2005 |
Curtis BM, Levin A, Parfrey PS. Multiple risk factor intervention in chronic kidney disease: Management of cardiac disease in chronic kidney disease patients Medical Clinics of North America. 89: 511-523. PMID 15755465 DOI: 10.1016/J.Mcna.2004.12.002 |
0.01 |
|
2005 |
Curtis BM, Ravani P, Malberti F, Kennett F, Taylor PA, Djurdjev O, Levin A. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes Nephrology Dialysis Transplantation. 20: 147-154. PMID 15585514 DOI: 10.1093/ndt/gfh585 |
0.01 |
|
2005 |
Curtis BM, Levin A. The Role of the Chronic Kidney Disease Clinic Chronic Kidney Disease, Dialysis, &Amp; Transplantation. 71-85. DOI: 10.1016/B978-1-4160-0158-4.50009-4 |
0.01 |
|
2003 |
Curtis BM, Barrett BJ, Parfrey PS. How to design a clinical trial Methods in Molecular Medicine. 86: 475-489. PMID 12886789 |
0.01 |
|
2002 |
Curtis BM, Barret BJ, Jindal K, Djurdjev O, Levin A, Barre P, Bernstein K, Blake P, Carlisle E, Cartier P, Clase C, Culleton B, Deziel C, Donnelly S, Ethier J, et al. Canadian survey of clinical status at dialysis initiation 1998-1999: a multicenter prospective survey. Clinical Nephrology. 58: 282-8. PMID 12400843 |
0.01 |
|
2002 |
Curtis BM, O'Keefe JH. Understanding the Mediterranean diet. Could this be the new "gold standard" for heart disease prevention? Postgraduate Medicine. 112: 35-8, 41-5. PMID 12198752 |
0.01 |
|
2002 |
Curtis BM, Parfrey PS. How can the cardiac death rate be reduced in dialysis patients? Seminars in Dialysis. 15: 22-24. PMID 11874586 |
0.01 |
|
2002 |
Curtis BM, O'Keefe JH. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clinic Proceedings. 77: 45-54. PMID 11794458 DOI: 10.4065/77.1.45 |
0.01 |
|
2002 |
Lavie CJ, Milani RV, O'Keefe JH, Curtis BM. Autonomic tone and benefits of cardiac rehabilitation programs [2] (multiple letters) Mayo Clinic Proceedings. 77: 398-399. |
0.01 |
|
2002 |
Curtis BM, O'Keefe J.H. J. Autonomic tone as a cardiovascular risk factor: The dangers of chronic fight or flight Mayo Clinic Proceedings. 77: 45-54. |
0.01 |
|
1992 |
Curtis BM, Scharnowske S, Watson AJ. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120 Proceedings of the National Academy of Sciences of the United States of America. 89: 8356-8360. PMID 1518869 |
0.01 |
|
1991 |
Curtis BM, Presnell SR, Srinivasan S, Sassenfeld H, Klinke R, Jeffery E, Cosman D, March CJ, Cohen FE. Experimental and theoretical studies of the three-dimensional structure of human interleukin-4. Proteins. 11: 111-9. PMID 1946344 DOI: 10.1002/prot.340110204 |
0.01 |
|
1991 |
Curtis BM, Williams DE, Broxmeyer HE, Dunn J, Farrah T, Jeffery E, Clevenger W, Deroos P, Martin U, Friend D, Craig V, Gayle R, Price V, Cosman D, March CJ, et al. Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein Proceedings of the National Academy of Sciences of the United States of America. 88: 5809-5813. PMID 1829529 DOI: 10.1073/Pnas.88.13.5809 |
0.01 |
|
1990 |
Larsen A, Davis T, Curtis BM, Gimpel S, Sims JE, Cosman D, Park L, Sorensen E, March CJ, Smith CA. Expression cloning of a human granulocyte colony-stimulating factor receptor: A structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains Journal of Experimental Medicine. 172: 1559-1570. PMID 2147944 DOI: 10.1084/JEM.172.6.1559 |
0.01 |
|
1990 |
Curtis BM, Widmer MB, Deroos P, Qwarnstrom EE. IL-1 and its receptor are translocated to the nucleus Journal of Immunology. 144: 1295-1303. PMID 2137488 |
0.01 |
|
1989 |
Lester HA, Snutch TP, Leonard JP, Nargeot J, Dascal N, Curtis BM, Davidson N. Expression of mRNA encoding voltage-dependent Ca channels in Xenopus oocytes. Review and progress report. Annals of the New York Academy of Sciences. 560: 174-82. PMID 2472764 DOI: 10.1111/J.1749-6632.1989.Tb24094.X |
0.01 |
|
1989 |
Curtis BM, Gallis B, Overell RW, McMahan CJ, DeRoos P, Ireland R, Eisenman J, Dower SK, Sims JE. T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1 Proceedings of the National Academy of Sciences of the United States of America. 86: 3045-3049. PMID 2470087 DOI: 10.1073/pnas.86.9.3045 |
0.01 |
|
1988 |
Catterall WA, Seagar MJ, Takahashi M, Curtis BM. Chapter 18 Molecular Properties of Voltage-Sensitive Calcium Channels Current Topics in Membranes and Transport. 33: 369-391. DOI: 10.1016/S0070-2161(08)60908-9 |
0.01 |
|
1987 |
Ice KS, Takahashi M, Curtis BM, Catterall WA. Comparison of molecular properties of the voltage-sensitive Ca2+ channel from longitudinal smooth muscle of rabbit ileum with the channel purified from transverse tubules of rabbit skeletal muscle Circulation Research. 61. PMID 2443272 |
0.01 |
|
1987 |
Catterall WA, Curtis BM. Molecular properties of voltage-sensitive calcium channels Society of General Physiologists Series. 41: 201-213. PMID 2436311 |
0.01 |
|
1986 |
Curtis BM, Catterall WA. Reconstitution of the voltage-sensitive calcium channel purified from skeletal muscle transverse tubules Biochemistry. 25: 3077-3083. PMID 2425846 DOI: 10.1021/BI00359A002 |
0.01 |
|
1985 |
Curtis BM, Catterall WA. Phosphorylation of the calcium antagonist receptor of the voltage-sensitive calcium channel by cAMP-dependent protein kinase Proceedings of the National Academy of Sciences of the United States of America. 82: 2528-2532. PMID 2581248 DOI: 10.1073/PNAS.82.8.2528 |
0.01 |
|
1984 |
Curtis BM, Catterall WA. Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules Biochemistry. 23: 2113-2118. PMID 6329263 DOI: 10.1021/BI00305A001 |
0.01 |
|
1983 |
Curtis BM, Catterall WA. Solubilization of the calcium antagonist receptor from rat brain Journal of Biological Chemistry. 258: 7280-7283. PMID 6305932 |
0.01 |
|
1983 |
Sarthy PV, Curtis BM, Catterall WA. Retrograde labeling, enrichment, and characterization of retinal ganglion cells from the neonatal rat Journal of Neuroscience. 3: 2532-2544. PMID 6140302 |
0.01 |
|
1981 |
Curtis BM, Scurlock JE. The mechanism of action of local anesthesia by tetraethylammonium derivatives Anesthesiology. 54: 270-277. PMID 6259968 |
0.01 |
|
1981 |
Scurlock JE, Curtis BM. Tetraethylammonium derivatives: Ultralong-acting local anesthetics? Anesthesiology. 54: 265-269. PMID 6259967 |
0.01 |
|
1980 |
Scurlock JE, Curtis BM. Dextran-local anesthetic interactions Anesthesia and Analgesia. 59: 335-340. PMID 6154432 |
0.01 |
|
1979 |
Curtis BM, Forno LS, Smith ME. Reactivation of neuritogenic activity of P2 protein from rabbit PNS myelin Brain Research. 175: 387-391. PMID 487166 DOI: 10.1016/0006-8993(79)91022-9 |
0.01 |
|
1979 |
Smith ME, Curtis BM. Frog sciatic nerve myelin: A chemical characterization Journal of Neurochemistry. 33: 447-452. PMID 112219 |
0.01 |
|
1974 |
Jain ML, Curtis BM, Bakutis EV. In vivo effect of LSD, morphine, ethanol and Δ9 tetrahydrocannabinol on mouse brain adenosine triphosphatase activity Res.Commun.Chem.Path.Pharmacol.. 7: 229-232. PMID 4272745 |
0.01 |
|
Hide low-probability matches. |